Your trusted source for investing success

Tag: CBD

Ready to invest in Cannabis? Get your guide today.

Click below to get an INN Insider's Report on marijuana investing (value of $49) for FREE. Limited time offer. No credit card required.

Give me my free guide!
Canadian Marijuana Stocks

Canadian Marijuana Stocks

The Canadian marijuana sector is one of the hottest growing sectors. Here’s a look at Canadian cannabis companies for investors to consider.

PUF Ventures Provides Corporate Update

PUF Ventures Provides Corporate Update

PUF Ventures Inc. (“PUF” or the “Company”) (CSE:PUF) (Frankfurt: PU3) (OTCPK: PUFXF), is pleased to provide the following corporate updates with respect to its various ongoing business development initiatives.

PUF Ventures Australia (“PVA”):

As was announced earlier today, PUF Ventures Inc.’s Australian unit has filed three applications with the Australian Office of Drug Control

Isodiol International Announces U.S. Sales Launch of Hops-derived CBD Product, ImmunAG™

Isodiol International Announces U.S. Sales Launch of Hops-derived CBD Product, ImmunAG™

Isodiol International Inc. (CSE:ISOL) (OTC:ISOLF) (FSE:LB6A.F) (the “Company” or “Isodiol”), a global Bioactive Phytoceutical innovator specializing in the development of pharmaceutical and nutraceutical products, announced today the U.S. sales launch of ImmunAG™, the market’s first non-cannabis cannabidiol (CBD) product derived from the hops plant. The time-released tablet will be unveiled at the Marijuana Business

PUF Ventures Australia Files Office of Drug Control Applications in Australia

PUF Ventures Australia Files Office of Drug Control Applications in Australia

PUF Ventures Inc. (“PUF” or the “Company”) (CSE: PUF) (Frankfurt: PU3) (OTCPK: PUFXF), an advanced Access to Cannabis for Medical Purposes Regulations (“ACMPR”) license applicant, is pleased to announce that PUF Ventures Australia has filed three applications with the Australian Office of Drug Control for the cultivation, production and manufacture

Satipharm Commences Sale of Medicinal Cannabis Capsules to Australian Patients

Satipharm Commences Sale of Medicinal Cannabis Capsules to Australian Patients

Harvest One Cannabis Inc. (TSXV:HVST) (“Harvest One” or the “Company”) through its wholly owned Swiss subsidiary, Satipharm AG (“Satipharm”), is pleased to advise that it’s Melbourne-based distribution partner, HL Pharma Pty Ltd (“HL Pharma”), has commenced distribution of Satipharm’s Gelpell-CBD™ capsules to approved patients in Australia.

Isodiol International Inc. Signs Letter of Intent to Acquire Bradley’s Bioscience Inc., Expands Into Vaping and THC Additive Industries

Isodiol International Inc. Signs Letter of Intent to Acquire Bradley’s Bioscience Inc., Expands Into Vaping and THC Additive Industries

Isodiol International Inc. (CSE:ISOL) (OTC:ISOLF) (FSE:LB6A.F) (the “Company” or “Isodiol”), a global Bioactive Phytoceutical innovator specializing in the development of pharmaceutical and wellness products, is pleased to announce the Company’s entrance into the vaping industry by signing a Letter of Intent (“LOI”) to acquire Bradley’s Bioscience Inc., a leading manufacturer

Enter Your Log In Credentials
This setting should only be used on your home or work computer.

×

Privacy & Legal Policy

Privacy Policy

×
Investing News Network

Send this to a friend

Hi,
I thought you might find this interesting:
Cannabis Weekly Round-Up: Quebec Reveals Marijuana Bill

URL: https://investingnews.com/daily/resource-investing/agriculture-investing/cannabis-investing/cannabis-weekly-roundup/